HeartFlow, Inc. (HTFL)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Non-invasive Coronary Artery Disease Detection Solutions	125.81M	Log In
Non-invasive Coronary Artery Disease Detection Solutions Growth	44.32%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	115.04M	Log In
United States Growth	48.00%	Log In
United Kingdom	5.19M	Log In
United Kingdom Growth	15.43%	Log In
Japan	4.30M	Log In
Japan Growth	7.34%	Log In
Rest of Europe	1.29M	Log In
Rest of Europe Growth	35.22%	Log In